News

The collaboration agreement is valued at €2.8m. As per the deal, BioFocus will provide expanded medicinal chemistry resource, biology services, and an option to perform ADME services for

The Phase III randomized, double-blind, placebo-controlled, parallel-design clinical study, assessed the safety and efficacy of Cialis 2.5 or 5 mg for once daily use in 606 sexually active

According to the deal, a new company Tasly-SemBioSys Pharmaceuticals will be set up in Tianjin, China, pharmabiz.com reported. The new project intends to develop and commercialize many products

DRP tested Skinvisible’s scientific data and validated the claims which said DermSafe is alcohol-free, offers protection from harmful bacteria, resists wash-off besides providing a moisture barrier for the

The order includes purchase of PrioClear, a prion capture resin incorporated into Octapharma’s manufacturing process for its solvent/detergent treated plasma product, Octaplas LG. The resumption of PrioClear supply

The vaccine, ID93/GLA-SE contains fusion protein of four antigens and a synthetic adjuvant formulation, which together enable T-cells to induce effective immunity and protect against TB ID93/GLA-SE will

The company inked a deal with Institute of Pharmacology and Toxicology of the Academy of Military Medical Sciences in China to complete final toxicology tests for AGX-1009, a

The vaccine targets and eliminates the alpha-synuclein protein, whose clumping is a sign of PD. PD01 vaccine has shown to stimulate the immune system to release antibodies that

The patent specifically covers the company’s RX-8243 which is currently in pre-clinical development. According to the company, RX-8243 has demonstrated potent anti-tumor properties in many cancer cell lines,